DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

718 Franse LV, Pahor M, Di Bari M, et al. Hypokalemia associated
with diuretic use and cardiovascular events in the Systolic
Hypertension in the Elderly Program. Hypertension, 2000,
35:1025–1030.
Gamba G, Saltzberg SN, Lombardi M, et al. Primary structure
and functional expression of a cDNA encoding the thiazidesensitive,
electroneutral sodium–chloride cotransporter. Proc
Natl Acad Sci USA, 1993, 90:2749–2753.
Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an
A 1
adenosine receptor antagonist, protects against the decline
in renal function observed with diuretic therapy. Circulation,
2002, 105:1348–1353.
Griebel G, Simiand J, Serradeil-Le Gal C, et al. Anxiolytic- and
anti-depressant-like effects of the nonpeptide vasopressin V 1b
receptor agonist SSR149415 suggest an innovative approach
for the treatment of stress-related disorders. Proc Natl Acad
Sci USA, 2002, 99:6370–6375.
Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effects
on sexual function of five antihypertensive drugs and nutritional
hygienic treatment in hypertensive men and women.
Treatment of Mild Hypertension Study (TOMHS). Hypertension,
1997, 29:8–14.
Guyton AC. Blood pressure control: Special role of the kidneys
and body fluids. Science, 1991, 252:1813–1816.
Inoue T, Terris J, Ecelbarger CA, et al. Vasopressin regulates apical
targeting of aquaporin-2 but not of UT1 urea transporter
in renal collecting duct. Am J Physiol, 1999, 276:F559–F566.
Isenring P, Forbush B III. Ion and bumetanide binding by the
Na–K–Cl cotransporter: Importance of transmembrane
domains. J Biol Chem, 1997, 272:24556–24562.
Kaplan MR, Mount DB, Delpire E. Molecular mechanisms of
NaCl cotransport. Annu Rev Physiol, 1996, 58:649–668.
Kawano Y, Matsuoka H, Nishikimi T, et al. The role of vasopressin
in essential hypertension: Plasma levels and effects of
the V 1
receptor antagonist OPC-21268 during different dietary
sodium intakes. Am J Hypertens, 1997, 10:1240–1244.
Kim GH, Masilamani S, Turner R, et al. The thiazide-sensitive
Na–Cl cotransporter is an aldosterone-induced protein. Proc
Natl Acad Sci USA, 1998, 95:14552–14557.
Kleyman, T.R., Sheng, S., Kosari, F., and Kieber-Emmons, T.
Mechanisms of action of amiloride: A molecular prospective.
Semin Nephrol, 1999, 19:524–532.
Knauf H, Mutschler E. Sequential nephron blockade breaks
resistance to diuretics in edematous states. J Cardiovasc
Pharmacol, 1997, 29:367–372.
Kovacs L, Robertson GL. Syndrome of inappropriate antidiuresis.
Endocrinol Metab Clin North Am, 1992, 21:859–875.
Krum H, Nolly H, Workman D, et al. Efficacy of eplerenone
added to renin–angiotensin blockade in hypertensive patients.
Hypertension, 2002, 40:117–123.
Kuan CJ, Herzer WA, Jackson EK. Cardiovascular and renal
effects of blocking A 1
adenosine receptors. J Cardiovasc
Pharmacol, 1993, 21:822–828.
Lane PH, Tyler LD, Schmitz PG. Chronic administration of
furosemide augments renal weight and glomerular capillary
pressure in normal rats. Am J Physiol, 1998, 275:F230–F234.
Lee CYW, Burnett JC Jr. Natriuretic peptides and therapeutic
applications. Heart Fail Rev, 2007, 12:131–142.
Lytle C, McManus TJ, Haas M. A model of Na–K–2Cl cotransport
based on ordered ion binding and glide symmetry. Am J
Physiol, 1998, 274:C299–C309.
SECTION III
MODULATION OF CARDIOVASCULAR FUNCTION
Manning M, Stoev S, Cheng LL, et al. Discovery and design of
novel vasopressin hypotensive peptide agonists. J Recept
Signal Transduct Res, 1999, 19:631–644.
Mannucci PM. Desmopressin (DDAVP) in the treatment of
bleeding disorders: The first 20 years. Blood, 1997, 90:
2515–2521.
Mount DB, Baekgaard A, Hall AE, et al. Isoforms of the
Na + –K + –2Cl cotransporter in murine TAL: I. Molecular
characterization and intrarenal localization. Am J Physiol,
1999, 276:F347–F358.
Nakamura S, Hirano T, Yamamura Y, et al. Effects of OPC-
51803, a novel, nonpeptide vasopressin V 2
-receptor agonist,
on micturition frequency in Brattleboro and aged rats. J
Pharmacol Sci, 2003, 93:484–488.
Nakamura S, Yamamura Y, Itoh S, et al. Characterization of a
novel nonpeptide vasopressin V 2
-receptor agonist, OPC-
51803, in cells transfected human vasopressin receptor subtypes.
Br J Pharmacol, 2000, 129:1700–1706.
Nielsen S, Kwon TH, Christensen BM, et al. Physiology and
patho-physiology of renal aquaporins. J Am Soc Nephrol,
1999, 10:647–663.
Nishimoto G, Zelenina M, Li D, et al. Arginine vasopressin stimulates
phosphorylation of aquaporin-2 in rat renal tissue. Am
J Physiol, 1999, 276:F254–F259.
Obermuller N, Bernstein P, Velazquez H, et al. Expression of the
thiazide-sensitive Na–Cl cotransporter in rat and human kidney.
Am J Physiol, 1995, 269:F900–F910.
Obermuller N, Kunchaparty S, Ellison DH, Bachmann S.
Expression of the Na–K–2Cl cotransporter by macula densa
and thick ascending limb cells of rat and rabbit nephron. J Clin
Invest, 1996, 98:635–640.
Ortega R, Ginès P, Uriz J, et al. Terlipressin therapy with and
without albumin for patients with hepatorenal syndrome:
Results of a prospective, nonrandomized study. Hepatology,
2002, 36:941–948.
Ouzan J, Perault C, Lincoff AM, et al. The role of spironolactone
in the treatment of patients with refractory hyper-tension.
Am J Hypertens, 2002, 15:333–339.
Payne JA, Forbush B III. Alternatively spliced isoforms of the
putative renal Na–K–Cl cotransporter are differentially distributed
within the rabbit kidney. Proc Natl Acad Sci USA,
1994, 91:4544–4548.
Perazella MA. Trimethoprim-induced hyperkalemia. Drug
Safety, 2000, 22:227–236.
Pitt B, Remme W, Zannad F, et al. for the Eplerenone Post-Acute
Myocardial Infarction Heart Failure Efficacy and Survival
Study Investigators. Eplerenone, a selective aldosterone
blocker, in patients with left ventricular dysfunction after
myocardial infarction. N Engl J Med, 2003, 348:1309–1321.
Pitt B, Zannad F, Remme W, et al., for the Randomized
Aldactone Evaluation Study Investigators. The effect of
spironolactone on morbidity and mortality in patients with
severe heart failure. Randomized Aldactone Evaluation Study
Investigators. N Engl J Med, 1999, 341:709–717.
Plata C, Meade P, Hall A, et al. Alternatively spliced isoform of
apical Na + –K + –Cl – cotransporter gene encodes a furosemidesensitive
Na + –Cl – cotransporter. Am J Physiol Renal Physiol,
2001, 280:F574–F582.
Plata C, Mount DB, Rubio V, et al. Isoforms of the Na–K–2Cl
cotransporter in murine TAL: II. Functional characterization
and activation by cAMP. Am J Physiol, 1999, 276:F359–F366.